Guard Therapeutics has obtained patent protection in Australia for their biological investigational drug ROSgard, both as product and for its use in medicine.
In addition to the patent grant in Australia (patent no. 2017235608), Guard Therapeutics has also received a Notice of Allowance in the US. Patent protection of ROSgard is currently under review in several other jurisdictions, including e.g. Europe, Japan, China, and Canada.